| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/26/2000 | EP1021185A1 Didhydropyrimidines and uses thereof |
| 07/26/2000 | EP1021184A1 Use of flunarizine for the topical treatment of glaucoma |
| 07/26/2000 | EP1021183A1 A COMBINATION OF A SELECTIVE 5-HT 1A? ANTAGONIST AND A SELECTIVE h5-HT 1B? ANTAGONIST OR PARTIAL AGONIST |
| 07/26/2000 | EP1021182A1 Indeno[1,2-c] pyrazole derivatives for inhibiting tyrosine kinase activity |
| 07/26/2000 | EP1021181A1 Carboxylic acid indole inhibitors of chemokines |
| 07/26/2000 | EP1021180A1 Mixed cyanoacrylate ester compositions |
| 07/26/2000 | EP1021179A1 Method of enhancing hair growth |
| 07/26/2000 | EP1021178A1 Selenophene anti-tumor agents |
| 07/26/2000 | EP1021177A1 Compositions and methods for prevention and treatment of vascular degenerative diseases |
| 07/26/2000 | EP1021176A1 Cobalt schiff base compounds |
| 07/26/2000 | EP1021175A1 Compounds and methods for therapeutic intervention in preventing diabetic complications |
| 07/26/2000 | EP1021174A2 Medicaments |
| 07/26/2000 | EP1021173A1 Use of csaid?tm compounds for the management of uterine contractions |
| 07/26/2000 | EP1021172A1 Dosage form for aerosol administration |
| 07/26/2000 | EP1021171A1 Delayed total release gastrointestinal drug delivery system |
| 07/26/2000 | EP1021169A1 Active agent transport systems |
| 07/26/2000 | EP1021148A1 Composition and method for acceleration of wound and burn healing |
| 07/26/2000 | EP1021139A1 Lipid soluble thiamine for prevention and treatment of age-related cognitive impairment |
| 07/26/2000 | EP1021087A1 Serotonin containing formulation for oral administration and method of use |
| 07/26/2000 | EP0827503B1 Pyrrolidinyl methyl indole salt |
| 07/26/2000 | EP0822808B1 Composite with sodium starch glycolate as a support material and products thereof |
| 07/26/2000 | EP0796245B1 Process for the preparation of amidino phenyl pyrrolidine beta-alanine urea analogs |
| 07/26/2000 | EP0787491B1 Preventive and remedy for type i allergic diseases |
| 07/26/2000 | EP0755253B1 Intranasal antimigraine composition |
| 07/26/2000 | EP0736011B1 Anellated dihydropyridines and their use in the production of pharmaceutical preparations |
| 07/26/2000 | EP0650374B1 Use of a calcium carbonate based porous material as support for a growth factor in the preparation of a bioabsorbable implant |
| 07/26/2000 | EP0639976B1 Use of terfenadine derivatives as antihistaminics in a hepatically impaired patient |
| 07/26/2000 | EP0576522B1 A single dose vaccination system |
| 07/26/2000 | EP0556393B1 Fused pyrazine derivative |
| 07/26/2000 | EP0556319B1 Sampangine derivatives useful as antifungal agents |
| 07/26/2000 | CN1261405A Process for preparing enantiomerically enriched N-derivatised lactams |
| 07/26/2000 | CN1261373A Compositions and methods for activating genes of interest |
| 07/26/2000 | CN1261372A Natural antitumor or antiviral substances and use of the same |
| 07/26/2000 | CN1261370A Method of producing tiazofurin and other C-nucleosides |
| 07/26/2000 | CN1261367A Alkyl-4-silylheterocyclic phenols and thiophenols as antioxidant agents |
| 07/26/2000 | CN1261366A Pyrrolothiazine and pyrrolothiazepine compounds having serotonin-2 receptor antagonistic and alpha-1-blocking action |
| 07/26/2000 | CN1261365A Crystalline macrolides and process for their preparation |
| 07/26/2000 | CN1261362A Omeprazole sodium salt |
| 07/26/2000 | CN1261361A 5-(2-Ethyl-2H-tetrazol-5-Y1)-1-methyl-1,2,3,6-tetrahydropyridine maleate |
| 07/26/2000 | CN1261358A Angiogenesis inhiting 5-substituted-1,2,4-thiadiazolyl derivatives |
| 07/26/2000 | CN1261354A Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p561ck tyrosine kinases |
| 07/26/2000 | CN1261353A Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p561ck tyrosine kinases |
| 07/26/2000 | CN1261352A New 'beta'-amino and 'beta'-azidocarboxylic acid derivatives, the production thereof and the use thereof as endothelin receptor an tagonists |
| 07/26/2000 | CN1261350A Tetrahydroisoquinoline derivatives as modulators of dopamine D3 receptors |
| 07/26/2000 | CN1261349A Chalcones having antiproliferactive activity |
| 07/26/2000 | CN1261287A Pharmaceutical formulations containing voriconazole |
| 07/26/2000 | CN1261284A Use of a CD40 : CD154 binding interruptor to prevent counter adaptive immune responses, particularly graft rejection |
| 07/26/2000 | CN1261280A Improved methods for processing activated protein C |
| 07/26/2000 | CN1261279A Pharmaceutical compositions containing eletriptan hemisulphate and caffeine |
| 07/26/2000 | CN1261278A Methods for treating inflammatory diseases using padprt inhibitors |
| 07/26/2000 | CN1261277A Novel substituted imidazole compounds |
| 07/26/2000 | CN1261276A Protease inhibitors |
| 07/26/2000 | CN1261275A Method and compositions for administering taxanes orally to human patients |
| 07/26/2000 | CN1261274A Carboxylic acids and derivatives thereof and pharmaceutical compositions containing them. |
| 07/26/2000 | CN1261273A Delayed-release dosage forms of sertraline |
| 07/26/2000 | CN1261272A Carcinostatics |
| 07/26/2000 | CN1261254A Nucleophile substituted ecteinascidins and N-oxide ecteinsacidins |
| 07/26/2000 | CN1261073A Tricyclooxime ethers, preparations thereof and medicinal compositions containing them |
| 07/26/2000 | CN1261072A 7-halogenated and 7 beta, 8 beta-methylene-taxinol, its usage against cancers and medicinal compositions containing it |
| 07/26/2000 | CN1260991A Drops for curing cold |
| 07/26/2000 | CN1260981A Antisanility mixture |
| 07/26/2000 | CN1260980A Oral-applied medicine for curing impotence and preparing process thereof |
| 07/26/2000 | CN1054856C New 19-nor steroids having phenoxyalkylsulphonemide or phenoxyalkylsulphonylurea chain in position llbeta, preparation process and intermediates, use as medicaments and pharmaceutical |
| 07/26/2000 | CN1054855C Non-reducing oligosaccharide and its production and use |
| 07/26/2000 | CN1054851C 3-aryl-pyrone derivatives and their preparing methods and uses as pesticides and herbicides |
| 07/26/2000 | CN1054850C Piperazine compounds used in therapy |
| 07/26/2000 | CN1054848C New benzopyran derivatives, their process of preparation and pharmaceutical compositions |
| 07/26/2000 | CN1054846C Use of intermediates for production of aromatic aminoalcohol derivatives having anti-diabetic and anti-obesity properties |
| 07/26/2000 | CN1054845C Quinoline compounds, their preparing methods and medicinal compositions |
| 07/26/2000 | CN1054844C N-substituted azabicycloheptane derivatives, their preparation and use |
| 07/26/2000 | CN1054842C 1-amidinophenyl-pyrrolidones piperidinones azetinones platelet aggregation inhibitors |
| 07/26/2000 | CN1054763C Specific remedy for curing dysentery and diarrhea of domestic animals and poultry |
| 07/26/2000 | CN1054746C Method for application of copper slicylacetate |
| 07/26/2000 | CN1054745C Antibiotic composition |
| 07/26/2000 | CN1054744C Aqueous agent |
| 07/26/2000 | CN1054743C Argatroban consentrated aqueous solution |
| 07/26/2000 | CN1054742C Improvements in or relating to benzothiophenes |
| 07/26/2000 | CN1054741C Medicinal composite for eyes |
| 07/25/2000 | US6093838 Amines substituted with a dihydro-benzofuranyl or with a dihydro-isobenzofuranyl group, an aryl or heteroaryl group and an alkyl group, having retinoid-like biological activity |
| 07/25/2000 | US6093828 Form of (E)-3-[6-[[(2,6-dichlorophenyl)-thio]methyl]-3-(2-phenylethoxy)-2-pyridi nyl]-2-propenoic acid |
| 07/25/2000 | US6093822 5-arylindole derivatives |
| 07/25/2000 | US6093820 Reacting an imide with a (substituted)alkoxyalkylsulfonic acid ester to form a n-alkoxyalkyl imide such as methoxymethyl ethosuximide; administering as anticonvulsant, antianxiety agent and muscle relaxant |
| 07/25/2000 | US6093814 Process for preparation of cefdinir |
| 07/25/2000 | US6093812 Process for the stereospecific synthesis of azetidinones |
| 07/25/2000 | US6093811 Oligonucleotide modulation of cell adhesion |
| 07/25/2000 | US6093802 Culturing cells transformed to express a nerve growth factor of specific amino acid sequence, activity, or weight and isolating protein; for treatment of alzheimer's/parkinson's diseases, amyotrophic lateral sclerosis, and nerve damage |
| 07/25/2000 | US6093748 Applying to an area of skin from which reduced hair growth is desired a dermatologically acceptable composition containing a non-steroidal suppressor of angiogenesis |
| 07/25/2000 | US6093747 1,7,7-trimethyl-bicyclo[2.2.1]heptane derivatives as anxiolytic agents having enhanced receptor specificity |
| 07/25/2000 | US6093746 Administering creatine |
| 07/25/2000 | US6093745 Methods and composition for treating skin proliferative diseases |
| 07/25/2000 | US6093743 Therapeutic methods employing disulfide derivatives of dithiocarbamates and compositions useful therefor |
| 07/25/2000 | US6093741 Agents with leukotriene B4-like activity as antiherpes viral agents |
| 07/25/2000 | US6093740 Therapeutic treatment for skin disorders |
| 07/25/2000 | US6093738 Imidazo(1,2-d)-thiadiazole compounds; peptic ulcer treatment |
| 07/25/2000 | US6093736 Antibacterial agents |
| 07/25/2000 | US6093735 Selective β-3 adrenergic agonists |
| 07/25/2000 | US6093733 Muscarinic receptor agonists |
| 07/25/2000 | US6093732 4-hydroxyquinoline-3-carboxamides and hydrazides as antiviral agents |
| 07/25/2000 | US6093730 Substituted isoquinoline-3-carboxamides, their preparation and their use as pharmaceuticals |
| 07/25/2000 | US6093729 Substituted bicyclic heteroaroylguanidines, a process for their preparation, their use as a medicament or a diagnostic agent, and a medicament containing them |